Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
data
3
×
life sciences
3
×
national blog main
national top stories
san francisco blog main
san francisco top stories
biotech
boston blog main
boston top stories
clinical trials
new york blog main
new york top stories
praluent
studies
adaptive biotechnologies
alicrocumab
american academy of neu
american academy of neurology
amgen
bicycle therapeutics
biogen
biopharma
board of directors
bostongene
boulder/denver blog main
boulder/denver top stories
canaan partners
cholesterol
clinical study
contepo
dementia
democrats
detroit blog main
detroit top stories
disease
eisai
enzyme
fbi raid
fda
fosfomycin
What
medicine
nasdaq
week
aces
america
announced
benefit
big
bio
biogen
ceo
cholesterol
continues
convoluted
democrats
dreams
drug
editing
flexible
gene
going
head
headaches
healthcare
holding
humans
inclisiran
insurance
ipo
isn't
key
landmark
little
lowering
meant
medco
medicines
morning
moves
open
Language
unset
Current search:
data
×
" life sciences "
×
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
